Company Filing History:
2 out of 694 
1 out of 2 Years Active: 2013-2019
Title: Cole Stewart: Innovator in Pharmaceutical Chemistry
Introduction
Cole Stewart is a notable inventor based in Ecublens, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at treating bacterial infections.
Latest Patents
Stewart holds three patents, with his latest innovations focusing on 2-homopiperazine-1-yl-4H-1,3-benzothiazine-4-one derivatives. These compounds are particularly useful in the treatment of serious bacterial infections, including tuberculosis, Buruli ulcer, and leprosy. Additionally, he has developed a process for the preparation of 2-(homo)piperazine 1,3-benzothiazine-4-one hydrochlorides, further enhancing the therapeutic potential of these derivatives.
Career Highlights
Throughout his career, Cole Stewart has worked with prestigious institutions such as École Polytechnique Fédérale de Lausanne and the Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute. His work in these organizations has allowed him to advance his research and contribute to significant scientific advancements.
Collaborations
Stewart has collaborated with notable colleagues, including Vadim Albertovich Makarov and Ute Moellmann, who have contributed to his research endeavors.
Conclusion
Cole Stewart's innovative work in pharmaceutical chemistry has the potential to make a significant impact on the treatment of bacterial infections. His patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.